S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
NYSEARCA:FTXH

First Trust Nasdaq Pharmaceuticals ETF Stock Forecast, Price & News

$25.91
+0.23 (+0.90%)
(As of 12/8/2021 12:00 AM ET)
Add
Today's Range
$25.69
$25.97
50-Day Range
$25.34
$27.28
52-Week Range
$24.63
$27.28
Volume
3,419 shs
Average Volume
6,678 shs
Market Capitalization
$16.84 million
P/E Ratio
N/A
Dividend Yield
0.91%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive FTXH News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer First Trust
Fund NameFirst Trust Nasdaq Pharmaceuticals ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:FTXH
Inception Date9/20/2016
Fund ManagerDaniel J. Lindquist, Jon C. Erickson, David G. McGarel, Roger F. Testin, Stan Ueland, Chris A. Peterson
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNasdaq US Smart Pharmaceuticals Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$16.72 million
Average Daily Volume$2.21 thousand
Discount/Premium-0.03%

ETF Expenses

Management Fee0.60%
Other Expenses0.00%
Total Expenses0.60%
Fee Waiver0.00%
Net Expenses0.60%

Administrator, Advisor and Custodian

AdministratorBrown Brothers Harriman & Co.
AdvisorFirst Trust Advisors L.P.
CustodianBrown Brothers Harriman & Co.
DistributorFirst Trust Portfolios L.P.
Transfer AgentBrown Brothers Harriman & Co.
Trustee
Lead Market MakerCredit Suisse

Geographic Exposure of FTXH

Currency Exposure of FTXH

Sector Exposure of FTXH

Industry Exposure of FTXH













First Trust Nasdaq Pharmaceuticals ETF (NYSEARCA:FTXH) Frequently Asked Questions

Is First Trust Nasdaq Pharmaceuticals ETF a good dividend stock?

First Trust Nasdaq Pharmaceuticals ETF pays an annual dividend of $0.23 per share and currently has a dividend yield of 0.91%.

What is First Trust Nasdaq Pharmaceuticals ETF's stock symbol?

First Trust Nasdaq Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "FTXH."

How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF?

Shares of FTXH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?

One share of FTXH stock can currently be purchased for approximately $25.91.

How much money does First Trust Nasdaq Pharmaceuticals ETF make?

First Trust Nasdaq Pharmaceuticals ETF has a market capitalization of $16.84 million.


This page was last updated on 12/9/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.